Published in Oncotarget on August 16, 2016
The functional network of ion channels in T lymphocytes. Immunol Rev (2009) 3.21
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR. Nature (2006) 2.34
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data. Neuropharmacology (1999) 2.32
Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity (2008) 2.23
The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem (2006) 2.13
T-bet in disease. Nat Immunol (2011) 2.09
Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol (2001) 1.85
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest (2003) 1.59
Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med (2000) 1.52
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol (2009) 1.29
Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc Natl Acad Sci U S A (2003) 1.25
Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J Alzheimers Dis (2009) 1.20
Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging (2009) 1.14
Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol Aging (2006) 1.13
Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07
Circulating cytokines in Alzheimer's disease. J Psychiatr Res (1998) 1.03
Blockade of T-lymphocyte KCa3.1 and Kv1.3 channels as novel immunosuppression strategy to prevent kidney allograft rejection. Transplant Proc (2009) 1.02
BK channels play a counter-adaptive role in drug tolerance and dependence. Proc Natl Acad Sci U S A (2010) 1.01
Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol (2012) 0.98
The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression. Drug Dev Res (2011) 0.98
Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun (2005) 0.96
Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol (2001) 0.95
Why is there so much CD45 on T cells? Immunity (2007) 0.94
Immune profiling of Alzheimer patients. J Neuroimmunol (2011) 0.94
Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases. Immunol Lett (2009) 0.93
NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo. Cell Mol Neurobiol (2010) 0.86
CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease. J Neuroimmunol (2002) 0.86
Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy. Neuromolecular Med (2007) 0.84
The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem Int (2007) 0.84
Effectiveness and safety of memantine treatment for Alzheimer's disease. J Alzheimers Dis (2013) 0.82
T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function. J Immunol (2014) 0.82
N-methyl-D-aspartate and sigma-ligands change the production of interleukins 8 and 10 in lymphocytes through modulation of the NMDA glutamate receptor. Neuroimmunomodulation (2009) 0.81
The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia. Biol Psychiatry (1999) 0.80
The inhibition of inwardly rectifying K+ channels by memantine in macrophages and microglial cells. Cell Physiol Biochem (2013) 0.80
Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells. Mol Cell Biol (2013) 0.80
The ion channel network in T lymphocytes, a target for immunotherapy. Clin Immunol (2011) 0.80
NMDA receptors as a possible component of store-operated Ca²⁺ entry in human T-lymphocytes. Biochemistry (Mosc) (2011) 0.79
Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer's disease. Neurobiol Dis (2009) 0.79
VGF expression by T lymphocytes in patients with Alzheimer's disease. Oncotarget (2015) 0.77
NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells. Cell Commun Signal (2014) 0.77
Functional study of T lymphocyte responsiveness in patients with dementia of the Alzheimer type. J Neuroimmunol (1989) 0.77
Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human Lymphocytes. PLoS One (2015) 0.84
N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias. Neurosci Res (2014) 0.80
DPP4-directed therapeutic strategies for MERS-CoV. Lancet Infect Dis (2014) 0.78
Assessment of modulated cytostatic drug resistance by automated γH2AX analysis. Cytometry A (2015) 0.78
Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro. Mol Cell Endocrinol (2015) 0.77
DNA double-strand breaks and micronuclei in human blood lymphocytes after repeated whole body exposures to 7T Magnetic Resonance Imaging. Neuroimage (2016) 0.75
Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology. Clin Rev Allergy Immunol (2017) 0.75
The role of zinc in liver cirrhosis. Ann Hepatol (2015) 0.75